These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2492585)

  • 1. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
    Stambuk D; Hawkins D; Gazzard BG
    J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
    J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
    Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
    Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine--the first year of experience.
    Williams I; Gabriel G; Cohen H; Williams P; Tedder RS; Machin S; Weller IV
    J Infect; 1989 Jan; 18 Suppl 1():23-31. PubMed ID: 2915140
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future trials with zidovudine.
    Yeo JM
    J Infect; 1989 Jan; 18 Suppl 1():93-6. PubMed ID: 2644366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L
    J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
    Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
    Zamora L; Gatell JM; Barrera JM; Ercilla G; Gil C; Buira E; Miro JM; Soriano E
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1181-5. PubMed ID: 1291319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
    Mulder JW; de Wolf F; Goudsmit J; Cload PA; Coutinho RA; Fiddian AP; Schellekens PT; van der Noordaa J; Lange JM
    Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
    Mitchell DM; Fleming J; Pinching AJ; Harris JR; Moss FM; Veale D; Shaw RJ
    Am Rev Respir Dis; 1992 Sep; 146(3):745-51. PubMed ID: 1519857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
    Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
    J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.